BP002106-PRO-405: Recombinant Human Adipose Differentiation-Related Protein (ADFP)
Source: E. Coli-derived.
Purity: > 95% as determined by SDS-PAGE.BP000291-C064: Recombinant Human C-C Motif Chemokine 16 (CCL16) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000291-CHM-237: Recombinant Human C-C Motif Chemokine 16 (CCL16) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract total human monocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000276-CHM-316: Recombinant Human C-C Motif Chemokine 8 (CCL8) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 76 amino acids and having a molecular mass of 8904 Dalton.
The biological activity was determined by measuring the dose dependent mobilization of intracellular calcium (calcium flux) with human THP-1 cells. Significant calcium mobilization is observed with 500 ug/ml of recombinant human MCP-2. Human MCP-2 also induces dose dependent chemotaxis of human THP-1 cells with an ED50=30-100 ug/ml corresponding to a Specific Activity of 10,000-33,334 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000289-CHM-001: Recombinant Human C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
The ED50 of CXCL14 as determined by its ability to induce calcium flux of prostaglandin E2 treated THP1 human acute monocytic leukemia cells was 1.0-10.0 ug/ml.
N-terminal sequence analysis: Ser-Lys-Cys-Lys-Cys.
Predicted molecular mass: 9.4 kDa.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000328-HOR-308: Human Endothelin-2
Purity > 95%, by RP-HPLC.BP000155-CYT-584: Recombinant Human IL-32alpha
Source: E. coli-derived.
Human IL-32 alpha activity is measured via the dose-dependent induction of TNF-alpha in the human THP-1 monocytic cell line.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000275-CHM-315: Recombinant Rat MCP-1 (CCL2)
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 125 amino acids and having a molecular mass of 14 kDa.
ED50 =1-10ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg. The biological activity was determined by measuring the dose dependent chemotaxis with human THP-1 cells. The optimal concentration should be determined for each specific application by an initial dose-response assay.
Purity > 95%, by SDS-PAGE.BP000301-CHM-259: Recombinant Mouse Thymus Expressed Chemokine (CCL25)
Source: E. coli-derived.
Fully biologically active. Determined by its ability to chemoattract human CCR9 transfected BaF3 mouse pro-B cells using a concentration range of 0.1-0.5 ug/ml corresponding to a Specific Activity of 2-10 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000301-CHM-364: Recombinant Human Thymus Expressed Chemokine (CCL25)
Source: E. coli-derived.
Determined by its ability to chemoattract human monocytes using a concentration range of 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.